Genvor Stock-Based Compensation Growth & History (GNVR)
Genvor's stock-based compensation was $4.9M for fiscal 2025.
View full Genvor company overviewGenvor annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $4.9M | $3.6M | +261.61% |
| 2024 | 2024-09-30 | $1.4M | $386,115 | +39.51% |
| 2023 | 2023-09-30 | $977,235 | −$2.5M | −72.18% |
| 2022 | 2022-09-30 | $3.5M | — | — |
| 2021 · Dec 31 | 2021-12-31 | $2.2M | — | — |
Genvor quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $116,700 | $54,200 | +86.72% |
| Q2 2026 | 2026-03-31 | $105,000 | $42,500 | +68.00% |
| Q1 2026 | 2025-12-31 | $125,000 | −$4.6M | −97.36% |
| Q4 2025 | 2025-09-30 | $67,500 | $67,500 | — |
| Q3 2025 | 2025-06-30 | $62,500 | $12,500 | +25.00% |
| Q2 2025 | 2025-03-31 | $62,500 | −$343,750 | −84.62% |
| Q1 2025 | 2024-12-31 | $4.7M | $3.8M | +422.27% |
| Q4 2024 | 2024-09-30 | $0 | — | — |
| Q3 2024 | 2024-06-30 | $50,000 | — | — |
| Q2 2024 | 2024-03-31 | $406,250 | — | — |
| Q1 2024 | 2023-12-31 | $907,100 | — | — |
| Q2 2022 | 2022-06-30 | $502,875 | $102,890 | +25.72% |
| Q1 2022 | 2022-03-31 | $3.0M | — | — |
| Q4 2021 | 2021-12-31 | $200,000 | — | — |
| Q3 2021 | 2021-06-30 | $399,985 | — | — |
Genvor stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-09-30, Genvor's stock-based compensation increased from $2.2M to $4.9M, a change of $2.7M. The latest reported quarter, Q3 2026, shows $116,700.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genvor source filings ↗